Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Brass

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Allergy and Asthma Reports|April 2, 2004
Implications of a switch from prescription to over-the-counter status for allergy drugsEric P Brass
Drugs|June 19, 2013
Intermittent claudication: new targets for drug developmentEric P Brass
Journal of General Internal Medicine|November 3, 2009
Basic biomedical sciences and the future of medical education: implications for internal medicineEric P Brass
Annals of the New York Academy of Sciences|December 14, 2004
Carnitine and sports medicine: use or abuse?Eric P Brass
The American Journal of Cardiology|November 3, 2004
Consumer behavior in the setting of over-the-counter statin availability: lessons from the consumer use study of OTC MevacorEric P Brass
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|September 11, 2013
Resident's morning report: an opportunity to reinforce principles of biomedical science in a clinical contextEric P Brass
Pharmacological Reviews|November 14, 2002
Pivalate-generating prodrugs and carnitine homeostasis in manEric P Brass
JAMA|August 7, 2003
Premature termination of clinical trialsEric P Brass
Therapeutic Innovation & Regulatory Science|October 18, 2023
The Term 'Deselect' is Ambiguous as Used in Research Studies to Support Prescription to Nonprescription SwitchesEric P Brass
Diabetes Care|May 23, 2013
Assessing the benefit-risk for new drugs: are the FDA's Endocrinologic and Metabolic Drugs Advisory Committee and the Division of Metabolism and Endocrinology Products in sync?Eric P Brass
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Allergy and Asthma Reports|April 2, 2004
Implications of a switch from prescription to over-the-counter status for allergy drugsEric P Brass
Drugs|June 19, 2013
Intermittent claudication: new targets for drug developmentEric P Brass
Journal of General Internal Medicine|November 3, 2009
Basic biomedical sciences and the future of medical education: implications for internal medicineEric P Brass
Annals of the New York Academy of Sciences|December 14, 2004
Carnitine and sports medicine: use or abuse?Eric P Brass
The American Journal of Cardiology|November 3, 2004
Consumer behavior in the setting of over-the-counter statin availability: lessons from the consumer use study of OTC MevacorEric P Brass
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|September 11, 2013
Resident's morning report: an opportunity to reinforce principles of biomedical science in a clinical contextEric P Brass
Pharmacological Reviews|November 14, 2002
Pivalate-generating prodrugs and carnitine homeostasis in manEric P Brass
JAMA|August 7, 2003
Premature termination of clinical trialsEric P Brass
Therapeutic Innovation & Regulatory Science|October 18, 2023
The Term 'Deselect' is Ambiguous as Used in Research Studies to Support Prescription to Nonprescription SwitchesEric P Brass
Diabetes Care|May 23, 2013
Assessing the benefit-risk for new drugs: are the FDA's Endocrinologic and Metabolic Drugs Advisory Committee and the Division of Metabolism and Endocrinology Products in sync?Eric P Brass
Pageof 8